Genflow Biosciences plc (LON:GENF – Get Free Report)’s share price was up 2.4% during mid-day trading on Monday . The company traded as high as GBX 2.20 and last traded at GBX 2.14. 832,539 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 2,331,012 shares. The stock had previously closed at GBX 2.09.
Genflow Biosciences Price Performance
The stock has a market cap of £12.12 million, a price-to-earnings ratio of -6.44 and a beta of 2.31. The firm’s 50-day moving average is GBX 2.25 and its 200 day moving average is GBX 2.02.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share for the quarter. Genflow Biosciences had a net margin of 840.76% and a return on equity of 377.33%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Recommended Stories
- Five stocks we like better than Genflow Biosciences
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
